This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Logan H Sigua: Innovator in Cancer Research
Introduction
Logan H Sigua is a prominent inventor based in North Sutton, NH (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on arginine methyltransferase 5 (PRMT5) degraders.
Latest Patents
Logan holds 1 patent for his invention titled "Arginine methyltransferase 5 (PRMT5) degraders and uses thereof." This patent discloses bifunctional compounds that target PRMT5 for degradation, along with compositions and methods for treating diseases or conditions mediated by aberrant PRMT5 activity.
Career Highlights
Logan is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in cancer treatment. His work focuses on developing innovative therapeutic strategies that can potentially improve patient outcomes.
Collaborations
Logan has collaborated with notable colleagues, including Jun Qi and Paul M Park, to further enhance the impact of his research in the scientific community.
Conclusion
Logan H Sigua's contributions to cancer research through his patented innovations exemplify the vital role of inventors in advancing medical science. His work continues to inspire future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile